Literature DB >> 11020266

Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus.

H M Aucken, M Warner, M Ganner, A P Johnson, J F Richardson, B D Cookson, D M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11020266     DOI： 10.1093/jac/46.4.639-a

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.

Authors:  Keso Skhirtladze; Doris Hutschala; Tatjana Fleck; Florian Thalhammer; Marek Ehrlich; Thomas Vukovich; Markus Müller; Edda M Tschernko
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.

Authors:  Mandy Wootton; Alasdair P MacGowan; Timothy R Walsh; Robin A Howe
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

4.  Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States Department of Veterans Affairs facilities.

Authors:  Stephen M Kralovic; Linda H Danko; Gary A Roselle
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

5.  Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Authors:  Hong Bin Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?

Authors:  Hala B Othman; Rania M Abdel Halim; Fatma Alzahraa M Gomaa; Malaka Z Amer
Journal:  Open Access Maced J Med Sci       Date:  2018-12-22

Review 7.  Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.

Authors:  Shanshan Zhang; Xiaoxi Sun; Wenjiao Chang; Yuanyuan Dai; Xiaoling Ma
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.